Skip to content

FRENCH OBSERVATORY OF ACUTE HEART FAILURE-2

FRENCH OBSERVATORY OF ACUTE HEART FAILURE-2

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05232058
Acronym
OFICA2
Enrollment
1593
Registered
2022-02-09
Start date
2021-03-22
Completion date
2023-04-30
Last updated
2025-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

In 2009, OFICA 1 provided a snapshot of the management of acute heart failure in France. Over the past 10 years, practitioners have observed a change in the profiles of hospitalized patients and it is necessary to specify the evolution of these characteristics, especially since the recommendations concerning management have changed significantly; this is the objective of this observatory. Like patients suffering from chronic diseases such as diabetes or asthma, heart failure patients are therefore at the center of their management. Compliance is improved when patients have understood the reason for the prescription. Ideally, compliance should not be achieved by respecting externally imposed norms, but rather by respecting norms that are understood, adapted, personalized and accepted. A self-questionnaire will thus be given to patients on the day of inclusion in the study. In heart failure patients with an average age of 80 years, systematic screening for cognitive disorders using a simple test recommended by the French National Authority for Health (Haute Autorité de Santé), the codex test, will make it possible to offer more appropriate care if necessary (geriatric or neurology consultation). Finally, follow-up at 3 months and at 1 and 2 years will be carried out by matching with data from the National Health Data System (SNDS)

Interventions

None listed

Sponsors

French Cardiology Society
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient hospitalized, regardless of the initial mode of admission, with acute heart failure (de novo heart failure or decompensation of chronic heart failure) of any severity and corresponding to one of the following clinical situations : 1. Pulmonary edema, hypertensive or not 2. Congestive heart failure (pulmonary congestion, peripheral oedema) 3. Cardiogenic shock 4. High output heart failure 5. Isolated right heart failure * Patient who agreed to participate in the study

Exclusion criteria

* Expressed refusal to participate in the study * Scheduled hospitalization for assessment * Surgical context (immediate postoperative period) * Diagnosis of acute heart failure reversed to another diagnosis before end of hospitalization

Design outcomes

Primary

MeasureTime frameDescription
Analyze survival during hospitalizationTrough length of hospitalization, an average of 10 daysRate of death during hospitalizaton

Secondary

MeasureTime frameDescription
Analyze survival at 2 years after hospitalisation2 years after hospitalisationRate of death at 2 years

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 15, 2026